Skip to main content

David Soler Segovia

Institutions of which they are part

Predoctoral researcher
Pneumology
Vall Hebron Institut de Recerca

David Soler Segovia

Institutions of which they are part

Predoctoral researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino, Letizia Traversi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 30/06/2025

Air pollution and microRNA expression in asthmatic patients: Effects on inflammatory and oxidative stress lung markers.

IP: Mª Jesús Cruz Carmona
Collaborators: David Soler Segovia
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI21/01346
Duration: 01/01/2022 - 31/12/2024

Caracterización y factores de riesgo de las SEcuelas PULmonares de los pacientes que superan una neumonía por COVID-19 (PULSE-COVID).

IP: Fco. Javier Muñoz Gall
Collaborators: Maria Angeles Jiménez Fuentes, Marc Miravitlles Fernández, David Clofent Alarcón, David Soler Segovia
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI21/01046
Duration: 01/01/2022 - 31/12/2024

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome (EXIMIOUS)

IP: Mª Jesús Cruz Carmona
Collaborators: Fco. Javier Muñoz Gall, David Espejo Castellanos, David Soler Segovia, Ana Villar Gomez
Funding agency: EUROPEAN COMMISSION
Funding: 395500
Reference: EXIMIOUS_H2020_SC1-BHC-2019
Duration: 01/01/2020 - 31/12/2024

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Rafael Parra López

Rafael Parra López

Head of group
Transfusional Medicine
Read more
Paredes Deiros, Carolina

Paredes Deiros, Carolina

Research technician
Stroke research
Read more
Alperi Garcia, Sofia

Alperi Garcia, Sofia

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Camacho Arteaga, Lina Fernanda

Camacho Arteaga, Lina Fernanda

Research technician
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.